Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants

Clinical trial NCT00938327 · COMPLETED

Trial details

NCT number: NCT00938327
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Infections, Rotavirus

Start date: 2009-08-03
Primary completion: 2010-02-20
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.